↓ Skip to main content

Peripheral arterial disease: Clinical assessment and indications for revascularization in the patient with diabetes

Overview of attention for article published in Current Diabetes Reports, January 2005
Altmetric Badge

Mentioned by

wikipedia
2 Wikipedia pages

Citations

dimensions_citation
33 Dimensions

Readers on

mendeley
41 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Peripheral arterial disease: Clinical assessment and indications for revascularization in the patient with diabetes
Published in
Current Diabetes Reports, January 2005
DOI 10.1007/s11892-005-0063-7
Pubmed ID
Authors

Bart E. Muhs, Paul Gagne, Peter Sheehan

Abstract

Peripheral arterial disease (PAD) is an under-recognized complication of diabetes. Recently, prevalence estimates in patients with diabetes over 50 years of age have been placed at 25% to 30%. The main reason for under-reporting is the largely asymptomatic nature of PAD in diabetes. Nonetheless, it is important to diagnose PAD because it is a marker of systemic atherosclerosis with excess cardiovascular risk, and it may identify a patient who may develop progressive disability and risk of limb loss. The most sensitive and specific diagnostic tool is an ankle-brachial index. Imaging studies are performed in patients who are candidates for revascularization. The most durable and effective revascularization procedure for PAD in diabetes is surgical bypass with saphenous vein as the conduit. Endovascular interventions are best used in patients with proximal disease with short-segment stenoses. The indications for revascularization have been immutable for decades, namely rest pain, ischemic ulceration, or gangrene. Presently, clinicians would include "selected" patients with intermittent claudication who have disabling symptoms and proximal disease above the inguinal ligament.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 41 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Nigeria 1 2%
Unknown 40 98%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 7 17%
Researcher 6 15%
Student > Doctoral Student 4 10%
Student > Ph. D. Student 4 10%
Other 3 7%
Other 10 24%
Unknown 7 17%
Readers by discipline Count As %
Medicine and Dentistry 19 46%
Nursing and Health Professions 5 12%
Agricultural and Biological Sciences 4 10%
Biochemistry, Genetics and Molecular Biology 2 5%
Social Sciences 1 2%
Other 1 2%
Unknown 9 22%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 23 August 2020.
All research outputs
#7,451,942
of 22,782,096 outputs
Outputs from Current Diabetes Reports
#389
of 1,006 outputs
Outputs of similar age
#35,993
of 139,619 outputs
Outputs of similar age from Current Diabetes Reports
#3
of 3 outputs
Altmetric has tracked 22,782,096 research outputs across all sources so far. This one is in the 44th percentile – i.e., 44% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,006 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.0. This one has gotten more attention than average, scoring higher than 50% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 139,619 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 17th percentile – i.e., 17% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 3 others from the same source and published within six weeks on either side of this one.